로딩 중…
지수 로딩 중…
진양제약
007370· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩3,875-1.77%
2026-06-19
Price Chart
진양제약-38.88%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 54.77B KRW |
| Revenue | 122.15B KRW |
| Net Income | 19.33B KRW |
| Total Assets | 271.49B KRW |
| Net Assets | 159.98B KRW |
| Employees | 213 |
| Value | |
| P/E | 2.83x |
| P/B | 0.34x |
| PEG | 41.61x |
| P/S | 0.45x |
| FCF Yield | -1.83% |
| Profitability | |
| ROE | 12.08% |
| ROA | 7.12% |
| Op. Margin | -2.73% |
| Revenue Growth | 4.72% |
| Earnings Growth | 0.07% |
| Financial Health | |
| Debt Ratio | 169.71% |
| Total Debt | 75.84B KRW |
| FCF | -1.00B KRW |
| Cash | 2.71B KRW |
| Current Ratio | 0.52x |
| Dividend | |
| Div. Yield | 3.80% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -38.88% |
| 1M Return | -13.12% |
| From 52W High | -43.76% |
| 1Y MDD | -42.58% |
| Trading | |
| Volume | 38,055 shares |
| Foreign Own. | 2.94% |
| Per Share | |
| EPS | 1,652 KRW |
| BPS | 11,318 KRW |
Company Info
Jinyang Pharmaceutical, a mid-sized company, was established in 1971 for manufacturing and selling pharmaceuticals, converted to a corporation in 1978, and listed on KOSDAQ in 2000. It produces prescription and over-the-counter drugs, with a focus on the circulatory system segment, aiming for differentiation through new drug development from its generic-centric business structure. The company pursues substantial growth by strengthening marketing for its core circulatory products, investing in R&D, and developing new products. It is also preparing to launch new products through domestic and international patents and technology partnerships. Jinyang Pharmaceutical is headquartered in Seocho-gu, Seoul.